Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies

Neurology

Volumn 54, Issue 5, 2000, Pages 1050-1058

  McKeith, Ian G ^a   Ballard, C G ^a   Perry, R H ^a   Ince, P G ^a   O'Brien, J T ^a   Neill, D ^a   Lowery, K ^a   Jaros, E ^a   Barber, R ^a   Thompson, P ^a   Swann, A ^a   Fairbairn, A F ^a   Perry, E K ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Clinical criteria; Dementia; Lewy bodies; Sensitivity and specificity

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CLINICAL ARTICLE; DEMENTIA; DIAGNOSTIC ERROR; FEMALE; HUMAN; HUMAN TISSUE; LEWY BODY; MALE; MULTIINFARCT DEMENTIA; NEUROPATHOLOGY; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; VISUAL HALLUCINATION;

EID: 18844481916     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.5.1050     Document Type: Article

References (41)

1. McKeith IG, Perry RH, Fairbairn AF Jabeen S, Perry EK. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992;22:911-922.
2. Byrne EJ, Lennox G, Godwin-Austen RB, et al. Dementia associated with cortical Lewy bodies. Proposed diagnostic criteria. Dementia 1991;2:283-284.
3. Hulette C, Mirra S, Wilkinson W, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IX. A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease. Neurology 1995;45:1991-1995
4. McKeith IG, Fairbairn AF, Perry RH, Thompson P. The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT). Br J Psychiatry 1994;165:324-332
5. Mega MS, Masterman DL, Benson F, et al. Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria. Neurology 1996;47:1403-1409.
6. Luis CA, Barker WW, Gajara K, et al. Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample. Int J Geriatr Psychiatry 1999;14: 526-533.
7. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB international workshop. Neurology 1996;47:1113-1124.
8. Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 1990;40:1-8.
9. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 1990;95:119-139.
10. Holmes C, Cairns N, Lantos P, Mann A. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 1999;174:45-50.
11. Del-Ser T, Munoz DG, Hachinski V. Temporal pattern of cognitive decline and incontinence is different in Alzheimer's disease and diffuse Lewy body disease. Neurology 1996;46:682-686.
12. Papka M, Rubio A, Schiffer RB. A review of Lewy body disease, an emerging concept of cortical dementia. J Neuropsychol Clin Neurosci 1998;10:267-279.
13. McKeith I, Fairbairn A, Perry R, Thompson P, Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 1992;305:673-678.
14. Shea C, MacKnight C, Rockwood R. Donepezil for treatment of dementia with Lewy bodies: a case series of nine patients. Int Psychogeriatr 1998;10:229-239.
15. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
16. Roman GC, Tatemischi T, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43: 250-260.
17. Copeland JRM, Kelleher J, Kellett JM, et al. A semi-structured clinical interview for the assessment and diagnosis of mental state in the elderly. Psychol Med 1976;6:439-449.
18. Dewey ME, Copeland JRM, Lobo A, Saz P, Dia SL. Computerised diagnosis from a Standardised History Schedule: a preliminary communication about the organic section of the HASAGECAT system. Int J Geriatr Psychiatry 1992;7:443-446.
19. Devanand DP, Miller L, Marder K, Bell K, Stern J. The Columbia University Scale for Psychopathology in Alzheimer's disease. Arch Neurol 1992;49:371-376.
20. Roth M, Tym E, Mountjoy C, et al. CAMDEX: a standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986;149:698-709.
21. Ballard C, McKeith I, Burn D, et al. The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies. Acta Neurol Scand 1997; 96:366-371.
22. Mirra SS, Heyman A, McKeel D, et al., and participating CERAD neuropathologists. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology 1991;41:479-486.
23. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
24. Tomlinson BE. Second Dorothy S. Russell Memorial Lecture. The neuropathology of Alzheimer's disease - issues in need of resolution. Neuropathol Appl Neurobiol 1989;15:491-512.
25. Lennox G, Lowe J, Landon M, et al. Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatry 1989;52:1236-1247.
26. Jaros E, Hall P, Ince P, Perry RH. Phosphorylated Tau is present in ubiquitin positive Lewy neurites (LN) in the CA2 region of the hippocampus in dementia with Lewy bodies. Neurobiol Aging 1998;19(4S):845. Abstract.
27. Altman G, Bland JM. Diagnostic tests 2: predictive values. BMJ 1994;309:102.
28. Kukull WA, Larson EB, Reifler BV, et al. The validity of three diagnostic criteria for Alzheimer's disease. Neurology 1990;40: 1364-1369.
29. Gold G, Giannakopoulos P, Montes-Paixao C Jr, et al. Sensitivity and specificity of newly proposed criteria for possible vascular dementia. Neurology 1997;49:690-694.
30. McKeith IG. Dementia with Lewy bodies: clinical and pathological diagnosis. Alzheimer Rep 1998;1:83-87.
31. Raghavan R, Khin NC, Brown A, et al. Detection of Lewy bodies in Trisomy 21 (Down's syndrome). Can J Neurol Sci 1993;20:48-51.
32. Baber R, Gholkar A, Ballard C, et al. White matter lesions on MRI in dementia with Lewy bodies, Alzheimer's disease, vascular dementia and normal ageing. J Neurol Neurosurg Psychiatry 1999;67:66-72.
33. McKeith IG, Perry EK, Perry RH. Diagnosis and treatment of dementia with Lewy bodies (DLB): report of the second DLB Internatonal Workshop. Neurology 1999;53:902-905.
34. Walker MP, Ayre GA, Wesnes K, O'Brien JT, McKeith IG, Ballard CG. A psychophysiological investigation of fluctuating consciousness in neurodegenerative dementia. Hum Psychopharmacol Clin Exp 1999;14:2483. Abstract.
35. Verghese J, Crystal HA, Dickson DW, Lipton RB. Validity of clinical criteria for the diagnosis of dementia with Lewy bodies. Neurology 2000 (in press).
36. Drach LM, Schubert S, Tews K-H, Bohl J, Steinmetz HEE. Evaluation of clinical diagnostic criteria for dementia with Lewy bodies. Neurobiol Aging 1998;19(4S):857. Abstract.
37. Papka M, Schiffer R, Rubio A. Diagnosing Lewy body disease: accuracy of clinical criteria in detecting Lewy body pathology. Neurobiol Aging 1998;19(4S):854. Abstract.
38. Barber R, Gholkar A, Scheltens P, et al. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies: a comparison with Alzheimer's disease, vascular dementia, and normal aging. Neurology 1999;52:1153-1158.
39. Piggott MA, Marshall EF, Thomas N, et al. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Brain 1999;122:1449-1468.
40. 123I-FP-CIT and SPECT. Lancet 1999;354: 646-647.
41. Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goerdert M. α-Synuclein in Lewy bodies. Nature 1997;388:839-840.